Nicholas Ashton
Works at
Lead investigator
Sources: openalex.org
Grants and prizes
Alzheimer's Drug Discovery Foundation
Diagnostics Accelerator, Determining %p-tau217 and MTBR-243 by immunoassay, ADDF-22806630, 2025–2027, Apr 1, 2025
R01, APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease, R01AG069453, 2020–2027, Apr 1, 2025
Sources: openalex.org, reporter.nih.gov